Effect of use of test product on vaginal microbiota - Open label test - - Effect of use of test product on vaginal microbiota - Open label test

Miura Clinic, Medical Corporation Kanonkai0 个研究点目标入组 25 人开始时间: 2022年12月19日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Subjects with a history of diabetes, liver disease, renal disease, gastrointestinal disease, heart disease, respiratory disease, peripheral vascular disease, or other serious disease (2) Subjects with diseases currently being treated (3) Subjects with a history of gynecological disease (endometriosis, uterine fibroids, ovarian cysts, cervical cancer, uterine cancer, etc.) (4) Subjects with food and drug allergies (5) Female subjects who wish to become pregnant while participating in this study, female subjects who are pregnant (including those who may be pregnant) or who are breastfeeding (6) Subjects using products or drugs that affect hormone balance (7) Subjects receiving antibiotics (8) Subjects who participate in strenuous sports and who are on a diet (9)Subjects with irregular lifestyle (10) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (11) Subjects who are continuously receiving medical treatment (including OTC and prescription drugs) (12) Subjects who consume alcohol excessively (13) Subjects who cannot abstain from alcohol from the day before the test to the day of the test (14) Subjects participating in or planning to participate in other clinical trials at the start of this study (15) Subjects who are otherwise judged by the principal investigator or subinvestigator to be unsuitable for the study

发起方

Miura Clinic, Medical Corporation Kanonkai